Interleukin-21 (recombinant IL-21)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Interleukin-21 (recombinant IL-21), covering 2014-07-21 to 2014-07-21. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma [Phase 2]